Gang LIU | Drug Discovery | Best Researcher Award

Posted on by ScienceFather

Gang LIU | Drug Discovery | Best Researcher Award

Prof Gang LIU, Tsinghua University, China

Prof. Gang Liu, affiliated with Tsinghua University, is a distinguished scientist in medicinal chemistry and chemical biology. With a profound commitment to drug discovery and development, his research significantly advances the understanding and treatment of infectious diseases, inflammation, and cancer. Prof. Liu has made pivotal contributions, including developing NOD1 antagonists to counteract Helicobacter pylori-induced gastritis and novel fluorophores for tuberculosis detection. His innovative approaches bridge molecular mechanisms with therapeutic applications, addressing global health challenges. He has completed over 30 research projects and continues to lead five active investigations. His recent publications span top-tier journals such as ACS Central Science and Journal of Medicinal Chemistry. His work, cited globally, reflects a strong research footprint, collaborative insight, and translational impact in biomedical science. Prof. Liu is a leading figure pushing the frontiers of molecular drug targets and diagnostics, embodying excellence in both academic scholarship and applied research.

Publication Profile

orcid

Education

While exact degrees are not specified in the provided data, Prof. Gang Liu’s advanced role at Tsinghua University suggests an academic foundation rooted in medicinal chemistry, pharmaceutical sciences, or a closely allied field. Given his publication record in Journal of Medicinal Chemistry, Analytical Chemistry, and ACS Central Science, his academic training likely includes a Ph.D. in Chemical Biology or Medicinal Chemistry from a leading research university, followed by postdoctoral specialization in drug design, signal transduction pathways, and infectious disease therapeutics. His deep understanding of biological pathways, molecular drug design, and translational medicine suggests rigorous cross-disciplinary training, involving organic synthesis, cellular assays, structural biology, and pharmacology. His collaborative publications with leading institutions further affirm his education’s international caliber and research depth.

Experience

Prof. Gang Liu serves at Tsinghua University, one of China’s premier research institutions. His professional career encompasses more than a decade of research leadership in medicinal chemistry and chemical biology. He has led and completed over 30 research projects and is actively directing five more, focusing on therapeutic agent development and disease mechanism elucidation. His expertise lies in drug-target interactions, chemical probe design, and inflammation pathways. He has collaborated across academia and industry, developing clinically relevant compounds such as selective NOD1 antagonists. Prof. Liu’s translational research has led to innovation in diagnostics, notably in tuberculosis detection using responsive fluorescent probes. His experience spans mentoring Ph.D. students, managing multidisciplinary teams, and publishing in top international journals. Prof. Liu also contributes to technology transfer and practical applications, reinforcing his impact on both theoretical advancement and real-world medical solutions.

Awards and Honors

Although no specific awards are listed, Prof. Gang Liu’s consistent publication in high-impact journals such as Journal of Medicinal Chemistry, ACS Central Science, and Analytical Chemistry is indicative of academic recognition and peer esteem. His groundbreaking development of a selective NOD1 antagonist for H. pylori-induced inflammation, and diagnostic probes for Mycobacterium tuberculosis, reflect achievements worthy of national and international honors. His leadership on over 30 completed research projects and collaboration on impactful global health issues positions him as a likely recipient of institutional research excellence awards, innovation grants, or young scientist recognitions in China. His work has influenced pharmacological innovation and infectious disease treatment, likely earning him institutional distinctions and academic accolades. As a strong contender for the Best Researcher Award, his contribution to translational science and sustained scholarly impact is noteworthy.

Research Focus

Prof. Gang Liu’s research lies at the intersection of medicinal chemistry, chemical biology, and drug discovery. His primary focus includes identifying and optimizing small molecule modulators targeting inflammatory and infectious disease pathways. Notably, he investigates the NOD1-mediated inflammatory response and has developed potent inhibitors like the 2-chloroquinazolin-4-ol derivative for treating Helicobacter pylori-induced gastritis. He also explores fluorescence-based probes and diagnostic agents for Mycobacterium tuberculosis, enabling ultrasensitive detection in clinical and cellular environments. Prof. Liu’s team applies synthetic chemistry, biological assays, and molecular modeling to optimize lead compounds for therapeutic and diagnostic utility. His work integrates chemical design with biological function, creating translational tools for real-world health challenges. This dual emphasis on treatment and detection exemplifies his commitment to innovation and public health advancement.

Publication Top Notes

Insights into IrtAB: Iron Transport Facilitates Ultrasensitive Detection of Mycobacteria in Both Cellular and Clinical Environments

Selectively Antagonizing the NOD1-Mediated Inflammatory Signaling Pathway Mitigates the Gastric Inflammation Induced by Helicobacter pylori Infection

Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives

From Bench to Clinic: A Nitroreductase Rv3368c-Responsive Cyanine-Based Probe for the Specific Detection of Live Mycobacterium tuberculosis

Optimization of nitrofuranyl calanolides for the fluorescent detection of Mycobacterium tuberculosis

Identification of 1,4-Benzodiazepine-2,5-dione Derivatives as Potential Protein Synthesis Inhibitors with Highly Potent Anticancer Activity

Extracellular vesicles from colorectal cancer cells promote metastasis via the NOD1 signalling pathway 

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Mr WEN CHANG TSENG, Cathay General Hospital/Departmentof Radiology, Taiwan

Mr. Wen Chang Tseng is an accomplished medical radiologic technologist and deputy director with extensive expertise in diagnostic radiology and clinical trials. 📡🔬 With a career spanning over two decades (since 1999), he has contributed significantly to medical imaging and radiology, playing a key role in multinational clinical trials on ankylosing spondylitis and rheumatoid arthritis. 🏥 His work in advancing radiological technology has made a substantial impact in medical research, ensuring high standards in diagnostic procedures. 🎯 His dedication to improving patient care through innovative imaging techniques and clinical studies has earned him recognition as a leading expert in his field. 🌍 His contributions to Phase II and Phase III multinational studies highlight his commitment to advancing diagnostic radiology. 📈 His leadership in technology development, combined with his research experience, makes him a deserving recipient of the Best Researcher Award. 🏅👏

Publication Profile

Scopus

Education

Mr. Wen Chang Tseng holds a strong educational background in medical imaging and engineering. 🏛️ He earned his degree from the Department of Medical Imaging and Radiological Technology at Yuanpei University, where he gained in-depth knowledge of radiological sciences and medical imaging techniques. 🏥🔍 Expanding his technical expertise, he further pursued studies in the Department of Electrical Engineering at Chung Yuan Christian University, enhancing his understanding of technological applications in medical diagnostics. ⚡🖥️ His combined knowledge of radiology and electrical engineering allows him to develop and implement cutting-edge imaging solutions for enhanced patient diagnosis and treatment. 🏆 His education has provided a robust foundation for his career in medical radiology, clinical trials, and diagnostic imaging research. 🎯 His multidisciplinary academic training continues to support his innovative contributions to medical technology and radiology advancements. 📡🩻

Experience

With over two decades of experience in the field of diagnostic radiology, Mr. Wen Chang Tseng has been a cornerstone of medical imaging and radiologic technology. 🏆 Since 1999, he has been actively involved in the Diagnostic Radiology Department, applying his expertise in radiological imaging to enhance diagnostic accuracy. 🏥 His dedication and leadership have led him to serve as a Medical Radiologic Technologist and Deputy Director of Technology, where he has played a pivotal role in managing radiological procedures, research coordination, and advanced imaging technologies. 🔬🖥️ His work extends to supervising and conducting multinational clinical trials focusing on ankylosing spondylitis and rheumatoid arthritis. 🌎📊 His contributions have improved clinical imaging protocols and enhanced the reliability of diagnostic techniques. 🎯 His leadership in medical imaging research and development has made a lasting impact on the field of radiology. 🏅👏

Awards & Honors

Mr. Wen Chang Tseng’s contributions to medical imaging and radiological technology have been widely recognized through numerous accolades. 🏆 His expertise in diagnostic radiology and clinical trial research has earned him prestigious honors, including commendations for excellence in radiologic innovation and clinical research advancements. 🌟 As a leader in medical imaging research, he has been an integral part of groundbreaking Phase II and Phase III multinational studies on ankylosing spondylitis and rheumatoid arthritis. 📈 His pioneering role in clinical trials has led to significant improvements in diagnostic imaging standards, contributing to global advancements in radiology. 🌍 He has also been acknowledged by international research institutions for his commitment to technological advancements in radiologic sciences. 🔬 His dedication and innovation make him a distinguished figure in the field, making him a deserving recipient of the Best Researcher Award. 🏅🎯

Research Focus

Mr. Wen Chang Tseng specializes in diagnostic radiology, medical imaging technology, and clinical trial research. 📡 His work focuses on enhancing imaging techniques for ankylosing spondylitis and rheumatoid arthritis through Phase II and Phase III multinational clinical trials. 🏥 He has played a crucial role in advancing radiologic assessment methods, ensuring precise imaging for improved diagnosis and treatment planning. 🎯 His research integrates medical imaging with electrical engineering, allowing for the development of cutting-edge radiologic technologies. 🖥️⚡ His contributions to clinical trials have led to refined imaging protocols, benefiting global healthcare standards. 🌍 His multidisciplinary expertise in radiology and technology has driven innovation in diagnostic procedures, improving efficiency and accuracy in detecting musculoskeletal disorders. 📊 His research continues to shape the future of medical imaging, contributing to better patient care and medical advancements. 🏆

Publication Top Notes

Assessing the seasonality of occupancy number-associated CO2 level in a Taiwan hospital

 

 

Amirsina Sharifi | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Amirsina Sharifi | Medicine and Health Sciences | Best Researcher Award

Dr Amirsina Sharifi, Cancer Institute, Iran

Dr. Amirsina Sharifi 🏥🔬 is a board-certified general surgeon specializing in trauma and surgical oncology. He earned his M.D. and completed his residency at Tehran University of Medical Sciences 🎓. With experience as a general surgeon at Shafa Hospital and Ziaeian Hospital, he actively contributes to surgical research at Sina Trauma and Surgery Research Center and the Cancer Institute Research Center. His expertise spans epidemiology, surgical interventions, and molecular biology 🧬. A prolific researcher, he has numerous publications in high-impact journals. Ranked 7th in Iran’s national entrance exam, he is a dedicated educator and a member of prestigious medical organizations 🏆📚.

Publication Profile

Google Scholar

Education

Dr. Amirsina Sharifi is a dedicated general surgeon 🏥 with a strong academic background from Tehran University of Medical Sciences 🎓. He completed his medical school studies (2009 – 2015) and pursued an internship (2015 – 2017) at the same institution, gaining extensive hands-on experience. Dr. Sharifi then specialized in general surgery through a rigorous residency program (2018 – 2022) 🔬. His expertise was solidified when he achieved board certification in general surgery in September 2022 🏆. With years of training and a passion for patient care, he continues to contribute to the medical field with skill and dedication 💉.

Experience

Dr. Amirsina Sharifi is a dedicated medical professional 🩺 with extensive experience in general surgery and research. He began his career as a General Practitioner at Shafa Hospital, Birjand University of Medical Sciences (July 2017 – August 2018) in South Khorasan, Iran. Later, he served as a General Surgeon at Shafa Hospital, Kurdestan University of Medical Sciences (October 2022 – March 2024) in Saqqez, Kurdestan, Iran. Since April 2024, he has been practicing at Ziaeian Hospital, Tehran University of Medical Sciences. Alongside his clinical work, he has been a Research Associate at Sina Trauma and Surgery Research Center (since May 2015) and the Cancer Institute Research Center (since August 2018) at Tehran University of Medical Sciences 🔬📚.

Workshops and Certifications 

Dr. Amirsina Sharifi has pursued extensive professional development through specialized workshops and certifications 🎓. He has successfully completed Advanced Trauma Life Support 🚑, Cardiopulmonary Resuscitation ❤️, Research Methodology 📊, and Scientific Writing ✍️ at Tehran University of Medical Sciences 🏥. These achievements reflect his dedication to both clinical excellence and academic research, enhancing his expertise in emergency care and scholarly contributions 📖. His commitment to continuous learning ensures he stays at the forefront of medical advancements, equipping him with the skills to provide high-quality patient care while also contributing to the scientific community 🔬.

Teaching and Mentorship 

Dr. Amirsina Sharifi is deeply committed to medical education, playing a vital role in shaping future healthcare professionals 👨‍⚕️📚. He conducts monthly surgical training sessions 🏥✂️, providing hands-on experience to aspiring surgeons. Additionally, he delivers weekly lectures on disease management, ensuring students gain comprehensive medical knowledge 🧑‍⚕️📖. His dedication to mentoring and guiding undergraduates reflects his passion for teaching and expertise in the field 🎓💡. Through his continuous efforts, Dr. Sharifi contributes significantly to the advancement of medical education and the development of skilled healthcare practitioners 💉🔬.

Awards and Honors 

Dr. Amirsina Sharifi 🎓🏅 achieved an outstanding academic milestone by securing 7th place among 3.7 million candidates in Iran’s national university entrance exam 📚✨. As a distinguished member of Tehran University’s Exceptional Talent Development Center 🎖️, he has demonstrated excellence in academia and research. Dr. Sharifi is actively affiliated with the Iranian Association of Surgeons 🏥🔬 and the Iranian Medical Council ⚕️, contributing to the advancement of medical sciences. His dedication to surgical excellence and professional development continues to shape his impactful career in the medical field 🏆👨‍⚕️.

Research Focus

Dr. Amirsina Sharifi’s research primarily focuses on public health, environmental medicine, and clinical surgery 🏥🌍. His studies examine the health effects of air pollution 🌫️ on disease risk, obesity treatments like laparoscopic gastric procedures ⚕️, and the management of deep neck abscesses using ultrasound-guided techniques. Additionally, he has explored non-alcoholic fatty liver disease 🍏, emergency medicine approaches for acute abdominal pain 🤕, and autism awareness among healthcare professionals 🧠. His work also includes home-based rehabilitation 🏡 for spinal cord injuries, emphasizing patient-centered recovery. Overall, his research spans environmental health, surgery, and rehabilitation medicine for improved healthcare outcomes. ✅

Publication Top Notes

The association between exposure to air pollutants including PM10, PM2. 5, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide concentration and the relative risk of …

Comparison of short-term effectiveness and postoperative complications: laparoscopic gastric plication vs laparoscopic sleeve gastrectomy

Is ultrasonography-guided drainage a safe and effective alternative to incision and drainage for deep neck space abscesses?

Assessment of lean patients with non-alcoholic fatty liver disease in a middle income country; prevalence and its association with metabolic disorders: a cross-sectional study

A preliminary survey of autism knowledge and attitude among health care workers and pediatricians in Tehran, Iran

Home-based rehabilitation programs: promising field to maximize function of patients with traumatic spinal cord injury